BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24067800)

  • 1. Assessment of vascularity in common blue nevi, small/medium congenital nevocellular, common and dysplastic acquired melanocytic nevi and melanomas: a comparative study.
    Ioannidis EN; Aroni K; Kavantzas N
    Am J Dermatopathol; 2014 Mar; 36(3):217-22. PubMed ID: 24067800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
    Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
    Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
    Einspahr JG; Thomas TL; Saboda K; Nickolof BJ; Warneke J; Curiel-Lewandrowski C; Ranger-Moore J; Duckett L; Bangert J; Fruehauf JP; Alberts DS
    Cancer; 2007 Dec; 110(11):2519-27. PubMed ID: 17932890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of vascularity in nodular melanoma and Spitz's nevus.
    Binder M; Steiner A; Mossbacher U; Hunegnaw M; Wolff K; Pehamberger H
    J Cutan Pathol; 1997 May; 24(5):272-7. PubMed ID: 9194579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.
    Konstantina A; Lazaris AC; Ioannidis E; Liossi A; Aroni K
    Melanoma Res; 2011 Oct; 21(5):389-94. PubMed ID: 21876459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplastic changes in different types of melanocytic nevi. A unifying concept.
    Toussaint S; Kamino H
    J Cutan Pathol; 1999 Feb; 26(2):84-90. PubMed ID: 10082398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nestin expression in cutaneous melanomas and melanocytic nevi.
    Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
    J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic nevi simulant of melanoma with medicolegal relevance.
    Massi G
    Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
    Sigg C; Pelloni F; Schnyder UW
    Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.
    Feinmesser M; Veltman V; Morgenstern S; Tobar A; Gutman H; Kaganovsky E; Tzabari C; Sulkes J; Okon E
    Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between melanocytic nevi and malignant melanoma.
    Friedman RJ; Rigel DS; Heilman ER
    Dermatol Clin; 1988 Apr; 6(2):249-56. PubMed ID: 3378371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
    Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Stratigos A; Patereli A; Katsambas A
    J Cutan Pathol; 2008 Sep; 35(9):799-808. PubMed ID: 18494826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Body distribution and density of acquired melanocytic nevi in adolescents of low socioeconomic status of Santiago, Chile].
    Zemelman D V; Molina C P; Valenzuela CY; Honeyman M J
    Rev Med Chil; 2008 Jun; 136(6):747-52. PubMed ID: 18769831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocytic nevi and malignant melanoma.
    Metcalf JS; Maize JC
    Dermatol Clin; 1985 Apr; 3(2):217-24. PubMed ID: 3830485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.